- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Aurobindo Pharma Limited — Updates, 04-03-2026: Press Release
04-03-2026 | 12:13 pm
04-03-2026 | 12:13 pm
Aurobindo Pharma's subsidiary, Eugia Pharma, launched Pomalidomide Capsules, a generic for the US$ 3.3 billion Pomalyst® market, in the US. Eugia was a first-to-market entrant, enhancing its specialty generics portfolio.
No comments yet. Be the first to comment!